跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
武 广昊
医学技术学院
h-index
956
引用
10
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2019
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(25)
相似学者
(2)
指纹图谱
深入其中 Guanghao Wu 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Adipose-Derived Mesenchymal Stem Cell
46%
Aldoxorubicin
11%
Aminolevulinic Acid Hexyl Ester
35%
Bacterial Outer Membrane
93%
Biosynthesis
11%
Cancer Immunotherapy
62%
Cancer Treatment
24%
Cancer Vaccine
41%
Chloride
35%
Cytotoxic T-Cell
15%
Dendritic Cell
31%
Foam Cell
23%
Heme
11%
Hybrid Cell
46%
Imine
15%
Immune Response
15%
Immunocompetent Cell
15%
Immunosuppressive Drug
23%
Immunotherapy
46%
Infancy
23%
Inhalational Drug Administration
46%
Lysophosphatidic Acid
17%
Membrane Microparticle
46%
Membrane Vesicle
93%
Mesenchymal Stem Cell
46%
Metastatic Carcinoma
15%
Neoplasm
93%
Nicotinamide Phosphoribosyltransferase
46%
Outer Membrane
15%
Photodynamic Therapy
46%
Phytochemical
93%
Platelet
46%
Polyphenol
46%
Porphyrin
9%
Programmed Death 1 Ligand 1
31%
Pulmonary Fibrosis
46%
Secretory Cell
23%
Sirtuin1
11%
Specific Tumor
15%
Systemic Administration
15%
T-Cell Response
15%
Tendinosis
46%
Tenocyte
11%
Thylakoid
100%
Thylakoid Membrane
67%
Tumor Microenvironment
15%
Tumor Vaccine
46%
Vesiculovirus
15%
Viral Protein
46%
Virus Glycoprotein
15%
Pharmacology, Toxicology and Pharmaceutical Science
3 Methyladenine
46%
6 Diazo 5 Oxonorleucine
23%
Adenosine Triphosphate
15%
Adjuvant
15%
Alder
15%
Aldoxorubicin
15%
Aminolevulinic Acid Hexyl Ester
15%
Antiinflammatory Agent
11%
Atherosclerosis
93%
Azide
23%
Bilateral Cancer
15%
Biocompatibility
23%
Biological Activity
23%
Brain Hemorrhage
46%
Cancer Vaccine
31%
Cardiovascular Disease
11%
Catalase
11%
Diseases
46%
Drug Delivery Vehicle
23%
Fenton Reaction
15%
Glycogen Synthase Kinase 3
11%
Hematologic Malignancy
15%
Heme
11%
Imine
54%
Immunotherapy
46%
Immunotoxicity
15%
Inflammation
11%
Lung Fibrosis
46%
Lysophosphatidic Acid
17%
Malignant Neoplasm
67%
Nanoclusters
70%
Neoplasm
46%
Neoplasm
27%
Phytochemical
46%
Receptor
11%
Side Effect
27%
Simvastatin
23%
Solid Malignant Neoplasm
93%
Systemic Administration
46%
Therapeutic Effect
46%
Tumor Antigen
46%
Tumor Growth
15%
Tumor Microenvironment
46%
Tumor Microenvironment
23%
Tumor Model
11%
Tumor Vaccine
46%
Vesiculovirus
23%
Viral Protein
46%
Virus Fusion Protein
11%
Virus Glycoprotein
23%
Immunology and Microbiology
Atherosclerosis
46%
Bacterial Outer Membrane
46%
Cancer Immunotherapy
15%
Cancer Vaccine
31%
CD47
23%
Cell Fusion
11%
Cell Population
9%
Cytotoxic T-Cell
15%
Dendritic Cell
31%
Foam Cell
11%
Hybrid Cell
46%
Immune Response
15%
Immunocompetent Cell
15%
Immunosuppressive Drug
15%
Immunotherapy
46%
Leukocyte Membrane
46%
Membrane Fusion
5%
Membrane Vesicle
46%
Mesenchymal Stem Cell
46%
Nicotinamide Phosphoribosyltransferase
46%
Nuclear Reprogramming
7%
Oncolytic Adenovirus
46%
Outer Membrane
15%
Oxidative Phosphorylation
46%
Photodynamics
46%
Platelet
46%
Programmed Death 1 Ligand 1
37%
Repolarization
18%
Tendinitis
46%
Tendinosis
46%
Tenocyte
11%
Thylakoid
62%
Thylakoid
46%
Thylakoid Membrane
39%
Tumor-Associated Macrophage
9%
Vesiculovirus
18%
Viral Protein
46%
